Jaume Puig

451 total citations
16 papers, 340 citations indexed

About

Jaume Puig is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Jaume Puig has authored 16 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Genetics and 2 papers in Surgery. Recurrent topics in Jaume Puig's work include Diabetes Management and Research (4 papers), Diabetes and associated disorders (4 papers) and Diabetes Treatment and Management (2 papers). Jaume Puig is often cited by papers focused on Diabetes Management and Research (4 papers), Diabetes and associated disorders (4 papers) and Diabetes Treatment and Management (2 papers). Jaume Puig collaborates with scholars based in Spain and United Kingdom. Jaume Puig's co-authors include Juana A. Flores-Le-Roux, Juan Pedro‐Botet, Juan F. Cano-Pérez, David Benaiges, Albert Goday, Juan J. Chillarón, María J. Carrera, José Palacios, Juan‐Miguel Jimenez and Manel López and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Jaume Puig

15 papers receiving 325 citations

Peers

Jaume Puig
Kirsteen Donaldson United Kingdom
George Razay United Kingdom
Bo Lumholtz Denmark
Susan Cornell United States
A J Scheen Belgium
J A Rees United Kingdom
L J Borthwick United Kingdom
Jaume Puig
Citations per year, relative to Jaume Puig Jaume Puig (= 1×) peers Aaruni Saxena

Countries citing papers authored by Jaume Puig

Since Specialization
Citations

This map shows the geographic impact of Jaume Puig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Puig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Puig more than expected).

Fields of papers citing papers by Jaume Puig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaume Puig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Puig. The network helps show where Jaume Puig may publish in the future.

Co-authorship network of co-authors of Jaume Puig

This figure shows the co-authorship network connecting the top 25 collaborators of Jaume Puig. A scholar is included among the top collaborators of Jaume Puig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaume Puig. Jaume Puig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Benaiges, David, Jaume Puig, Jesús Lafuente, et al.. (2012). Biochemical behaviour of an incidentally diagnosed silent corticotroph adenoma.. PubMed. 33(3). 290–3. 1 indexed citations
2.
Chillarón, Juan J., Juana A. Flores-Le-Roux, Albert Goday, et al.. (2010). Metabolic Syndrome and Type-1 Diabetes Mellitus: Prevalence and Associated Factors. Revista Española de Cardiología (English Edition). 63(4). 423–429. 29 indexed citations
3.
Chillarón, Juan J., Juana A. Flores-Le-Roux, Albert Goday, et al.. (2010). Síndrome metabólico y diabetes mellitus tipo 1: prevalencia y factores relacionados. Revista Española de Cardiología. 63(4). 423–429. 30 indexed citations
4.
Chillarón, Juan J., Albert Goday, Juana A. Flores-Le-Roux, et al.. (2009). Estimated Glucose Disposal Rate in Assessment of the Metabolic Syndrome and Microvascular Complications in Patients with Type 1 Diabetes. Molecular Endocrinology. 23(9). 1520–1520. 5 indexed citations
5.
Chillarón, Juan J., Albert Goday, Juana A. Flores-Le-Roux, et al.. (2009). Estimated Glucose Disposal Rate in Assessment of the Metabolic Syndrome and Microvascular Complications in Patients with Type 1 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 94(9). 3530–3534. 104 indexed citations
6.
Puig, Jaume, et al.. (2007). Diabetes team consultation: Impact on length of stay of diabetic patients admitted to a short-stay unit. Diabetes Research and Clinical Practice. 78(2). 211–216. 25 indexed citations
7.
Peláez, Núria, et al.. (2005). Intraoperative gamma probe detection of lymph node recurrence of insulinoma. Journal of Surgical Oncology. 91(3). 209–211. 4 indexed citations
8.
Supervía, August, et al.. (2003). Unidad de estancia corta: una forma de optimizar recursos hospitalarios. Revista de Calidad Asistencial. 18(5). 315–315. 1 indexed citations
9.
Bou, Josep, Teresa Domènech, Jaume Puig, et al.. (2000). Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine. European Journal of Pharmacology. 410(1). 33–41. 31 indexed citations
10.
Puig, Jaume. (1999). Reptes en la gestió de la prestació farmacèutica. 6–13. 2 indexed citations
11.
Mauri, Silvia, et al.. (1999). [Painless subacute thyroiditis with negative antithyroid antibodies during alpha interferon treatment in chronic hepatitis C].. PubMed. 113(16). 636–636. 1 indexed citations
12.
Crespo, M., Núria Godessart, Juan‐Miguel Jimenez, et al.. (1999). Synthesis and Biological Evaluation of 3,4-Diaryloxazolones:  A New Class of Orally Active Cyclooxygenase-2 Inhibitors. Journal of Medicinal Chemistry. 43(2). 214–223. 86 indexed citations
13.
Puig, Jaume, J Lloveras, Hernando Knobel, et al.. (1996). Victims of cyanide poisoning make suitable organ donors. Transplant International. 9(1). 87–88. 12 indexed citations
14.
Fernández, Andrés G., Jaume Puig, Jörge Beleta, et al.. (1992). Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis. European Journal of Pharmacology. 222(2-3). 257–264. 6 indexed citations
15.
Kelly, M.E., et al.. (1992). PANCOPRIDE, A NEW 5-HT3 ANTAGONIST WITH POTENT ANXIOLITIC PROPERTIES IN RODENTS AND PRIMATES. Behavioural Pharmacology. 3(Supplement). 43–43.
16.
Puig, Jaume, et al.. (1990). Pancopride: a novel 5-HT3 antagonist with potent antiemetic action. European Journal of Pharmacology. 183(4). 1214–1214. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026